Literature DB >> 27055943

The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.

Simone Göschl1, Hristo P Varbanov2, Sarah Theiner3, Michael A Jakupec4, Markus Galanski1, Bernhard K Keppler3.   

Abstract

The current study aims to elucidate the possible reasons for the significantly different pharmacological behavior of platinum(IV) complexes with cisplatin-, carboplatin- or nedaplatin-like cores and how this difference can be related to their main physicochemical properties. Chlorido-containing complexes are reduced fast (within hours) by ascorbate and are able to unwind plasmid DNA in the presence of ascorbate, while their tri- and tetracarboxylato analogs are generally inert under the same conditions. Comparison of the lipophilicity, cellular accumulation and cytotoxicity of the investigated platinum compounds revealed the necessity to define new structure-property/activity relationships (SPRs and SARs). The higher activity and improved accumulation of platinum(IV) complexes bearing Cl(-) in equatorial position cannot only be attributed to passive diffusion facilitated by their lipophilicity. Therefore, further platinum accumulation experiments under conditions where active/facilitated transport mechanisms are suppressed were performed. Under hypothermic conditions (4°C), accumulation of dichloridoplatinum(IV) complexes is reduced down to 10% of the amount determined at 37°C. These findings suggest the involvement of active and/or facilitated transport in cellular uptake of platinum(IV) complexes with a cisplatin-like core. Studies with ATP depletion mediated by oligomycin and low glucose partially confirmed these observations, but their feasibility was severely limited in the adherent cell culture setting.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular accumulation; Cytotoxicity; Facilitated/active transport; Lipophilicity; Platinum(IV) complexes; Redox behavior

Mesh:

Substances:

Year:  2016        PMID: 27055943     DOI: 10.1016/j.jinorgbio.2016.03.005

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

1.  Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models.

Authors:  Simone Göschl; Ekaterina Schreiber-Brynzak; Verena Pichler; Klaudia Cseh; Petra Heffeter; Ute Jungwirth; Michael A Jakupec; Walter Berger; Bernhard K Keppler
Journal:  Metallomics       Date:  2017-03-22       Impact factor: 4.526

2.  Multifunctional αvβ6 Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting.

Authors:  Anne C Conibear; Sonja Hager; Josef Mayr; Matthias H M Klose; Bernhard K Keppler; Christian R Kowol; Petra Heffeter; Christian F W Becker
Journal:  Bioconjug Chem       Date:  2017-08-10       Impact factor: 4.774

3.  The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study.

Authors:  Sarah Theiner; Márkó Grabarics; Luis Galvez; Hristo P Varbanov; Nadine S Sommerfeld; Mathea S Galanski; Bernhard K Keppler; Gunda Koellensperger
Journal:  Dalton Trans       Date:  2018-04-17       Impact factor: 4.569

4.  New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action.

Authors:  Kateryna Ohui; Eleonora Afanasenko; Felix Bacher; Rachel Lim Xue Ting; Ayesha Zafar; Núria Blanco-Cabra; Eduard Torrents; Orsolya Dömötör; Nóra V May; Denisa Darvasiova; Éva A Enyedy; Ana Popović-Bijelić; Jóhannes Reynisson; Peter Rapta; Maria V Babak; Giorgia Pastorin; Vladimir B Arion
Journal:  J Med Chem       Date:  2018-12-18       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.